Convergence Investment Partners, LLC Laboratory Corp Of America Holdings Transaction History

Convergence Investment Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$271.6 - $314.21 $236,020 - $273,048	-869 Closed	0 $0
Q3 2021 Oct 25, 2021	BUY	$274.82 - $308.34 $238,818 - $267,947	869 New	869 $245,000
Q2 2018 Aug 07, 2018	SELL	$160.33 - $189.41 $3.25 Million - $3.83 Million	-20,242 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$161.53 - $178.11 $3.27 Million - $3.61 Million	20,242 New	20,242 $3.27 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.